BioSpace News Archive

Applied DNA Sciences, Inc., and Nutrition21, LLC, announce the successful implementation of Applied DNA’s CertainT authenticity and traceability solution for Nutrition21’s leading sports supplement ingredient, Nitrosigine®.

Motif FoodWorks, the animal-free ingredient innovation company, today announced a partnership with the University of Massachusetts Amherst to optimize the process of characterizing functional properties of food proteins, including their solubility, stability, color and other properties critical to the production of successful plant-based products.

The International Atomic Energy Agency (IAEA) today published its final report following an 11-day mission to review Canada’s emergency preparedness and response framework for nuclear and radiological emergencies.

Dr. Tom Price joins with the Arizona Foundation and AHPA to announce the introduction of lower cost association health plans exclusively for Arizona medical professionals

DreaMed Diabetes Ltd., the developer of personalized diabetes management solutions, and DexCom Inc., the leader in continuous glucose monitoring (CGM) for people with diabetes, announced a data partnership agreement

As a new and powerful weapon against the spread of the coronavirus, Chinese hospitals are now deploying Danish disinfection robots from UVD Robots.

Triennial report examines utilization and billed charges, along with emerging innovations associated with single- and multiple-organ and tissue transplants

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced a correction to its unaudited loss per share calculation for the fourth quarter ended December 31, 2019.

Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Prometra II Programmable Pump System for use with intrathecal baclofen. Flowonix introduced the Prometra II 40mL pump to the US market in November 2019,

Ribon Therapeutics, a clinical stage biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions, today announced it will be presenting at two upcoming scientific conferences.